Founded in Columbus, Ohio, in 2014, Slate Run Pharmaceuticals is a pharmaceutical company led by industry veterans with more than 200 years of combined experience in generic medicines. The company supplies FDA-approved pharmaceuticals to healthcare customers, with a particular focus on dependable access to generic injectables.
U.S. FDA approval for listed generic products
Compliance program
XGen Pharmaceuticals DJB, IncFounded in 1972 by Dan Badia and his wife, Shirley Harmening, XGen Pharmaceuticals DJB develops and supplies affordable generic pharmaceuticals, with a focus on injectables for hospitals, clinics and institutional customers. The privately held, family-owned and woman-owned company grew from a three-product operation in Northport, New York into a Horseheads-based business whose portfolio preserves essential past-patent treatments, including products such as eribulin mesylate injection. XGen DJB holds NABP accreditation and reports more than 50 years of experience in generic pharmaceuticals.BIG FLATS, NY
Oakwood LabsFounded in 1997 in the Cleveland area, Oakwood Labs develops and manufactures sustained-release injectable pharmaceuticals through its proprietary Chroniject™ polymer microsphere platform. Its integrated operation connects formulation research and development with an FDA-approved aseptic cGMP facility, supporting products from early feasibility through clinical supply and commercial manufacturing. Oakwood has worked on more than 100 long-acting injectable projects and currently manufactures five FDA-approved commercial products.OAKWOOD VILLAGE, OH
STI Pharma, LLCFounded in 2008 by industry executive Anup Dam, privately owned STI Pharma develops, licenses, acquires and commercializes generic medicines. The company manages product development and regulatory support in-house, while its commercial products are made at FDA-registered partner facilities and distributed across the United States and its territories. STI is particularly active in specialty and injectable generics, including recent launches such as thiotepa and isoproterenol hydrochloride.NEWTOWN, PA
Chartwell Pharmaceuticals LLCChartwell Pharmaceuticals operates four manufacturing and analytical campuses in the New York metropolitan area, developing and producing generic prescription medicines in a broad range of dosage forms. With a leadership team whose members bring more than 20 years of generic-pharmaceutical experience apiece, the company handles work from formulation trials and clinical supplies through commercial production in fully cGMP-compliant facilities. Its U.S.-made portfolio includes more than 1,100 FDA-approved Orange Book listings and products compliant with the Trade Agreements Act and Buy American Act.CONGERS, NY